Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Colorcon
McKinsey
Dow

Last Updated: August 10, 2022

Litigation for CUBICIN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


US Court Litigation for CUBICIN

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,468,967 Cubist Pharmaceuticals Inc. v. Hospira Inc. See Plans and Pricing 2012-03-21 2014-12-07 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,468,967 Cubist Pharmaceuticals Inc. v. Hospira Inc. See Plans and Pricing 2012-03-21 2014-12-08 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,468,967 Cubist Pharmaceuticals Inc. v. Hospira Inc. See Plans and Pricing 2012-09-17 2015-06-22 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,468,967 Cubist Pharmaceuticals LLC. v. Mylan Laboratories Limited See Plans and Pricing 2013-10-09 2016-02-01 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,468,967 In Re Copaxone 40 MG Consolidated Cases See Plans and Pricing 2014-09-10 2017-01-30 35:271 Patent Infringement District Court, D. Delaware Defendant See Plans and Pricing
6,468,967 See Plans and Pricing See Plans and Pricing 2015-12-16 2016-03-01 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,468,967 Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC See Plans and Pricing 2016-02-09 2016-03-10 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for CUBICIN

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,468,967 Agila Specialties Inc. See Plans and Pricing 2014-10-23 10-23-2014 Cubist Pharmaceuticals, Inc. Inter partes review See Plans and Pricing 04-28-2015 FREDERICK OLESON See Plans and Pricing
6,468,967 Fresenius-Kabi USA LLC See Plans and Pricing 2014-11-03 11-03-2014 Cubist Pharmaceuticals LLC Inter partes review See Plans and Pricing 05-14-2015 FREDERICK OLESON See Plans and Pricing
6,852,689 Agila Specialties Inc. See Plans and Pricing 2014-10-23 10-23-2014 Cubist Pharmaceuticals Incorporated Inter partes review See Plans and Pricing 04-28-2015 Frederick Oleson See Plans and Pricing
6,852,689 Fresenius-Kabi USA LLC See Plans and Pricing 2014-11-03 12-01-2014 Cubist Pharmaceuticals LLC Inter partes review See Plans and Pricing 05-14-2015 Frederick Oleson See Plans and Pricing
8,058,238 Agila Specialities Inc. See Plans and Pricing 2014-10-23 10-23-2014 Cubist Pharmaceuticals, Inc. Inter partes review See Plans and Pricing 04-28-2015 Thomas Kelleher See Plans and Pricing
8,058,238 Agila Specialities Inc. See Plans and Pricing 2014-10-23 10-23-2014 Cubist Pharmaceuticals, Inc. Inter partes review See Plans and Pricing 04-28-2015 Thomas Kelleher See Plans and Pricing
8,058,238 Agila Specialities Inc. See Plans and Pricing 2014-10-23 10-23-2014 Cubist Pharmaceuticals, Inc. Inter partes review See Plans and Pricing 04-28-2015 Thomas Kelleher See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Dow
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.